Emergent BioSolutions (EBS) Short Interest Ratio & Short Volume → This Wall Street stock prediction just went viral (From Chaikin Analytics) (Ad) Free EBS Stock Alerts $5.72 +0.64 (+12.59%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Emergent BioSolutions Short Interest DataCurrent Short Volume7,130,000 sharesPrevious Short Volume5,890,000 sharesChange Vs. Previous Month+21.05%Dollar Volume Sold Short$13.40 millionShort Interest Ratio / Days to Cover1.2Last Record DateApril 30, 2024Outstanding Shares52,400,000 sharesFloat Size50,470,000 sharesShort Percent of Float14.13%Today's Trading Volume3,120,563 sharesAverage Trading Volume4,530,255 sharesToday's Volume Vs. Average69% Short Selling Emergent BioSolutions ? Sign up to receive the latest short interest report for Emergent BioSolutions and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEBS Short Interest Over TimeEBS Days to Cover Over TimeEBS Percentage of Float Shorted Over Time Ad Paradigm PressBiden to Drop BOMBSHELL June 13th?Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th!Click here now to see his shocking evidence. Emergent BioSolutions Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20247,130,000 shares $13.40 million +21.1%14.1%1.2 $1.88 4/15/20245,890,000 shares $11.63 million +3.3%11.8%2 $1.98 3/31/20245,700,000 shares $14.42 million +16.1%11.4%1.9 $2.53 3/15/20244,910,000 shares $12.00 million -20.8%9.8%1.6 $2.45 2/29/20246,200,000 shares $19.96 million -46.3%12.5%2.1 $3.22 2/15/202411,540,000 shares $19.68 million +10.5%23.2%4.2 $1.71 Get the Latest News and Ratings for EBS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emergent BioSolutions and its competitors with MarketBeat's FREE daily newsletter. 1/31/202410,440,000 shares $17.43 million -11.7%21.0%7.8 $1.67 1/15/202411,820,000 shares $24.23 million +1.3%23.8%8.6 $2.05 12/31/202311,670,000 shares $28.01 million +3.0%23.5%8.4 $2.40 12/15/202311,330,000 shares $26.85 million +0.8%22.8%7.8 $2.37 11/30/202311,240,000 shares $24.05 million +4.3%22.6%6.6 $2.14 11/15/202310,780,000 shares $23.82 million -1.4%21.7%5.1 $2.21 10/31/202310,930,000 shares $22.84 million +21.9%22.0%4.7 $2.09 10/15/20238,970,000 shares $22.60 million +14.1%18.1%3.7 $2.52 9/30/20237,860,000 shares $26.72 million -16.9%15.8%3.3 $3.40 9/15/20239,460,000 shares $37.27 million +12.8%19.0%4 $3.94 8/31/20238,390,000 shares $39.35 million -9.3%16.8%3.9 $4.69 8/15/20239,250,000 shares $48.01 million +5.4%18.6%5.6 $5.19 7/31/20238,780,000 shares $60.36 million +5.0%18.1%5.8 $6.88 7/15/20238,360,000 shares $60.28 million +8.3%17.2%6.2 $7.21 6/30/20237,720,000 shares $56.66 million +9.8%15.9%5.3 $7.34 6/15/20237,030,000 shares $56.91 million +3.7%16.2%3.9 $8.10 5/31/20236,780,000 shares $57.83 million +6.8%15.5%3.9 $8.53 5/15/20236,350,000 shares $58.99 million -4.5%14.4%3.4 $9.29 4/30/20236,650,000 shares $58.72 million -7.5%15.1%3.7 $8.83 4/15/20237,190,000 shares $85.20 million -5.4%17.7%4.2 $11.85 3/31/20237,600,000 shares $78.74 million +22.4%18.7%4.6 $10.36 3/15/20236,210,000 shares $59.93 million +11.7%15.3%5.5 $9.65 2/28/20235,560,000 shares $68.83 million -1.1%13.7%5.1 $12.38 2/15/20235,620,000 shares $83.85 million No Change13.9%5.6 $14.92 1/31/20235,620,000 shares $74.13 million +4.9%13.9%5.7 $13.19 1/15/20235,360,000 shares $71.98 million -3.8%13.2%5.4 $13.43 12/30/20225,570,000 shares $65.78 million +63.3%13.7%5.8 $11.81 12/15/20223,410,000 shares $37.99 million +45.7%8.4%3.7 $11.14 11/30/20222,340,000 shares $28.78 million -9.0%5.7%2.9 $12.30 11/15/20222,570,000 shares $34.21 million +19.0%6.3%3.4 $13.31 10/31/20222,160,000 shares $45.06 million +6.4%5.3%3.4 $20.86 10/15/20222,030,000 shares $39.44 million -9.4%5.0%3.1 $19.43 9/30/20222,240,000 shares $47.02 million +9.3%5.5%3.4 $20.99 9/15/20222,050,000 shares $47.27 million +5.1%5.0%3.3 $23.06Tiny AI projects with huge promise hiding in plain sight … (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. EBS Short Interest - Frequently Asked Questions What is Emergent BioSolutions' current short interest? Short interest is the volume of Emergent BioSolutions shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 7,130,000 shares of EBS short. 14.13% of Emergent BioSolutions' shares are currently sold short. Learn More on Emergent BioSolutions' current short interest. What is a good short interest ratio for Emergent BioSolutions? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EBS shares currently have a short interest ratio of 1.0. Learn More on Emergent BioSolutions's short interest ratio. What is a good short interest percentage for Emergent BioSolutions? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.13% of Emergent BioSolutions' floating shares are currently sold short. Is Emergent BioSolutions' short interest increasing or decreasing? Emergent BioSolutions saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 7,130,000 shares, an increase of 21.1% from the previous total of 5,890,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Emergent BioSolutions' float size? Emergent BioSolutions currently has issued a total of 52,400,000 shares. Some of Emergent BioSolutions' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Emergent BioSolutions currently has a public float of 50,470,000 shares. How does Emergent BioSolutions' short interest compare to its competitors? 14.13% of Emergent BioSolutions' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Emergent BioSolutions: XOMA Co. (2.33%), Vanda Pharmaceuticals Inc. (4.17%), Merrimack Pharmaceuticals, Inc. (5.80%), Verastem, Inc. (3.49%), Rigel Pharmaceuticals, Inc. (3.23%), Regulus Therapeutics Inc. (7.33%), Lexicon Pharmaceuticals, Inc. (9.52%), OPKO Health, Inc. (26.42%), Innoviva, Inc. (18.39%), Ironwood Pharmaceuticals, Inc. (13.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Emergent BioSolutions stock? Short selling EBS is an investing strategy that aims to generate trading profit from Emergent BioSolutions as its price is falling. EBS shares are trading up $0.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Emergent BioSolutions? A short squeeze for Emergent BioSolutions occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EBS, which in turn drives the price of the stock up even further. How often is Emergent BioSolutions' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EBS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: XOMA Short Interest Data VNDA Short Interest Data MACK Short Interest Data VSTM Short Interest Data RIGL Short Interest Data RGLS Short Interest Data LXRX Short Interest Data OPK Short Interest Data INVA Short Interest Data IRWD Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:EBS) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts